A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1989
10/31/1989	US4877608 Sodiuum chloride and-or potassium chloride, lysine hydrochloride, and histidine
10/31/1989	CA1262600A1 Products comprising oligosaccharides, preparation process of said products and biological and biochemical applications of the same
10/31/1989	CA1262550A1 Dipeptide compounds having pharmaceutical activity and compositions containing them
10/31/1989	CA1262527A1 Composition for increasing the efficiency of poultry production
10/25/1989	EP0339009A2 Method for improving the efficacy of insect toxins
10/25/1989	EP0338916A1 Haemoglobin macromolecular complexes, method of preparation and their uses
10/25/1989	EP0338846A2 Monoclonal antibodies
10/25/1989	EP0338679A2 Tumour necrosis factor in the treatment of bladder cancer
10/25/1989	EP0338634A2 Viper venom polypeptides and genetic expression
10/25/1989	EP0338620A1 Recovery of hepatitis B surface antigen
10/25/1989	EP0338566A2 Pertussis toxoid vaccine
10/25/1989	EP0338508A2 Esters from amino-acids, their preparation process, drugs containing same and their use
10/25/1989	EP0338437A2 Synthetic vaccins against foot and mouth disease and their preparation process
10/25/1989	EP0338436A2 Monoclonal antibody against neuropeptide Y, method for its preparation as well as its use
10/25/1989	EP0338409A1 Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same
10/25/1989	EP0338395A2 Monoclonal antibodies to Pseudomonas aeruginosa, their production and use
10/25/1989	EP0338229A1 Preparation with antibody activity and a large spectrum of action, remedy consisting of or containing it and its use for the treatment of bacterial or toxin-induced diseases and for combatting protozoa
10/25/1989	EP0338062A1 Drug comprising the association of polymyxin b, tobramycin and amphotericin b administered by spraying
10/25/1989	EP0192657B1 Monoclonal antibody directed to human ganglioside gd 2?
10/25/1989	EP0103196B1 Pasteurized human fibrinogen, method of preparing it and its use
10/25/1989	CN1036509A Method of enhancing mental fanction
10/24/1989	US4876367 Macrocyclic polyether carboxylic acids
10/24/1989	US4876332 Heparin binders; cellular adhesion promoters; coatings for medical equipment and bandages
10/24/1989	US4876260 Nervous system disorders
10/24/1989	US4876243 Diuretics
10/24/1989	US4876242 Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast
10/24/1989	US4876199 Cancer diagnosis and treatment
10/24/1989	US4876194 Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
10/24/1989	US4876089 Envelope glycoprotein
10/19/1989	WO1989009833A1 Luminide and macroluminide class of pharmaceuticals
10/19/1989	WO1989009831A1 Lak cell cytotoxin
10/19/1989	WO1989009818A1 Processes for purifying phospholipase a2 and producing phospholipase a2-like polypeptides
10/19/1989	WO1989009817A1 Composition and method for acceleration of clot lysis
10/19/1989	WO1989009792A1 Method for potentiating and inhibiting insulin-like growth factor activity
10/19/1989	WO1989009791A1 Dna encoding androgen receptor protein
10/19/1989	WO1989009789A1 Human monoclonal antibodies against rabies virus
10/19/1989	WO1989009788A2 Biosynthetic osteogenic proteins and osteogenic devices containing them
10/19/1989	WO1989009787A2 Osteogenic devices
10/19/1989	WO1989009786A1 Peptide derivatives
10/19/1989	WO1989009785A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation
10/19/1989	WO1989009782A1 New anti-receptor peptides and therapeutic agents
10/19/1989	WO1989009624A1 Solubilization of proteins for pharmaceutical compositions
10/19/1989	WO1989009622A1 Il-2 receptor-specific chimeric antibodies
10/19/1989	WO1989009621A2 Compounds for diagnosis and/or therapy of tumours
10/19/1989	WO1989009615A1 Heparin-containing formulations
10/19/1989	WO1989009614A1 Human growth hormone formulation
10/19/1989	WO1989009613A1 Protective agent for radiation hazard
10/19/1989	WO1989009612A1 FACTOR VII/VIIa ACTIVE SITE INHIBITORS
10/19/1989	WO1989009611A1 Cyclic analogs of atrial natriuretic peptides
10/19/1989	WO1989009610A1 Tumor necrosis factor formulations
10/19/1989	WO1989009609A1 Solvent system for chronic vascular infusion of hydrophobic drugs
10/19/1989	WO1989009606A1 Pharmaceutical for treating tumors in humans and method for making it
10/19/1989	WO1989009605A1 Bone-inducing protein
10/19/1989	WO1989009227A3 Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis
10/19/1989	DE3910667A1 Peptide derivatives
10/19/1989	DE3910323A1 Biologically active proteins
10/19/1989	DE3811193A1 Peptides, process for their preparation and pharmaceutical compositions containing these peptides
10/18/1989	EP0337967A2 Compositions inducing the binding between parts of living mineralized tissue
10/18/1989	EP0337817A2 Plasminogen activator and thrombolytic agent
10/18/1989	EP0337799A2 14-Beta-gal mammalian lectins
10/18/1989	EP0337774A2 CCK antagonists
10/18/1989	EP0337731A2 Peptide antibiotics
10/18/1989	EP0337714A2 HIV protease inhibitors useful for the treatment of aids
10/18/1989	EP0337613A1 Device comprising means for protecting and dispensing fluid sensitive medicament
10/18/1989	EP0337604A1 Novel Bacillus thuringiensis gene encoding a coleopteran active toxin
10/18/1989	EP0337430A2 Antitumor antibiotic kedarcidin
10/18/1989	EP0337359A2 Lymphokine production and purification
10/18/1989	EP0337334A2 Renin-inhibiting amino acid derivatives
10/18/1989	EP0337295A2 Renin-inhibiting N-heterocyclic dipeptides
10/18/1989	EP0337203A2 Aglycons of A/16686 antibiotics
10/18/1989	EP0336976A1 Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis
10/18/1989	EP0336958A1 Product containing as active principles: a) a peptide having an activity of the type of that of human gamma interferon, b) hydroxyurea
10/18/1989	EP0195817B1 Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
10/18/1989	CN1036332A Wound healing
10/17/1989	US4874844 Arginine-lysine-glutamic acid; stimulates maturation of immature t-cells and their function
10/17/1989	US4874746 Mixture of transforming growth factor alpha and platelet-derived growth factor
10/17/1989	US4874744 Topical application
10/17/1989	US4874743 Antiinflammatory agents
10/17/1989	US4874742 Synthetic whole blood and a process for preparing the same
10/17/1989	US4874705 Immunizing chickens
10/17/1989	US4874609 3'-azido-3'-deoxythmidine and interferons; aids
10/17/1989	US4874608 Administering leukocyte-derived stimulants for the immune system including di- and tripeptides of threonine and glycine and derivatives
10/17/1989	CA1262400A1 Process for the manufacture of glucosamine derivatives
10/17/1989	CA1262399A1 Gnrh antagonists
10/17/1989	CA1262334A1 Steroidal liposomes
10/12/1989	EP0288478A4 Use of growth hormone for nitrogen retention under hypocaloric conditions.
10/12/1989	EP0262178A4 Amino acid chelated compositions for delivery to specific biological tissue sites.
10/11/1989	EP0336760A2 Bone-inducing protein
10/11/1989	EP0336736A1 Purification of pertussis toxins and production of vaccine
10/11/1989	EP0336693A2 Acceleration of clot lysis
10/11/1989	EP0336631A2 Improved cytotoxic therapy
10/11/1989	EP0336562A1 Improvements relating to antigens
10/11/1989	EP0336554A1 Novel peptide and salts thereof and peptide antiallergic agents containing these peptides
10/11/1989	EP0336405A2 Anti-human cancer protein complexes, their production and use
10/11/1989	EP0336326A2 3-Aminodihydrothiophene-2-one peptide derivatives, processes for the preparation and therapeutic use
10/11/1989	EP0336230A2 Cyclic peptide antagonists of Substance P and Substance K
10/11/1989	EP0335966A1 Vasoconstrictive substances in combination with cytotoxic agents
10/11/1989	EP0335900A1 Human interleukin-4 muteins
10/11/1989	CN1036204A Prodn. of heterocyclic compound
10/11/1989	CN1036135A Growth inhibiting agent and use thereof

1 ... 3050 3051 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 ... 3163